The nonsteroidal anti-inflammatory drugs reduces the risk of certain types of cancer, say U.S. researchers..
A team of research Institute Sanford-Burnham found that non-steroidal anti-inflammatory drug (NSAID) Sulindac (Sulindac) suppresses the growth of tumors. Currently, this drug is used to treat arthritis pain.
The study showed that it is able to stop the development of cancer with a modified version of RXR-α protein. But some NSAIDs known serious side effects. Because scientists have created a new version of the drug K-80003, which excludes negative effects on the heart.
The researchers explained that, depending on conditions, the protein RXR α can stop or stimulate the growth of malignant cells. Modified K-80003 contributes to the destruction of cancer cells (apoptosis).